Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Comment by deninsaskon Dec 12, 2006 9:43pm
219 Views
Post# 11856407

RE: I don't get why you guys don't just.......

RE: I don't get why you guys don't just....... Either way franko13 now I don't have to read zipdats lacklustre posts! Passing Gas is my guess. Share price could surprise a lot of people in the next couple weeks leading into the anticipated E1-INT results. A continuation of buying from south of the border would propel us back up to 52 week highs again and there are other announcements expected at absolutely anytime. If results for E1-INT are in January look forward to Both Trials being released simultaneously. That would be my preferred approach if I had anything to do with it....lol Sounds like E1-IT Trial results will be announced using mainly the 3 month data currently being interpreted and compilation of the remaining 3 months will just be a formality that takes zero time because it is mostly safety and most of the efficacy is contained in the first 3 months. Novo has 60 days after receipt of the 6 month data to make a decision on how to move forward with this. Geez might be just in time for our Nasdaq listing! Also sounds like Cruz fully expects to be included in one or more of the Market Indices this coming year. Another exciting year to look forward to! GLA
Bullboard Posts